trying...
37088423 2023 06 19 2023 06 19 1469-0691 29 7 2023 Jul Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases Clin Microbiol Infect Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2. 876 886 876-886 10.1016/j.cmi.2023.04.019 S1198-743X(23)00192-1 Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first set of guidelines on SARS-CoV-2 in vitro diagnosis in February 2022. Because the COVID-19 landscape is rapidly evolving, the relevant ESCMID guidelines panel releases an update of the previously published recommendations on diagnostic testing for SARS-CoV-2. This update aims to delineate the best diagnostic approach for SARS-CoV-2 in different populations based on current evidence. An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was established, half appointed by the chair, and the remaining selected with an open call. The panel met virtually once a week. For all decisions, a simple majority vote was used. A list of clinical questions using the population, intervention, comparison, and outcome (PICO) format was developed at the beginning of the process. For each PICO, 2 panel members performed a literature search focusing on systematic reviews with a third panellist involved in case of inconsistent results. The panel reassessed the PICOs previously defined as priority in the first set of guidelines and decided to address 49 PICO questions, because 6 of them were discarded as outdated/non-clinically relevant. The 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)-adoption, adaptation, and de novo development of recommendations (ADOLOPMENT)' evidence-to-decision framework was used to produce the guidelines. After literature search, we updated 16 PICO questions; these PICOs address the use of antigen-based assays among symptomatic and asymptomatic patients with different ages, COVID-19 severity status or risk for severe COVID-19, time since the onset of symptoms/contact with an infectious case, and finally, types of biomaterials used. Copyright © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Fragkou Paraskevi C PC First Department of Critical Care Medicine & Pulmonary Services, Evangelismos General Hospital, National and Kapodistrian University of Athens, Athens, Greece; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece. De Angelis Giulia G European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy. Menchinelli Giulia G European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy; Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, Rome, Italy. Can Fusun F European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Department of Medical Microbiology, Koc University School of Medicine, Istanbul, Turkey; Koc University IsBank Research Centre for Infectious Diseases (KUISCID), Istanbul, Turkey. Garcia Federico F European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Servicio de Microbiología Clínica, Hospital Universitario Clínico San Cecilio, Instituto de Investigación Biosanitaria, Ibs. Granada, Granada, Spain; Centro de Investigación Biomédicaen Red Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain. Morfin-Sherpa Florence F European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Laboratory of Virology, Institut des Agents Infectieux, National Reference Centre for Respiratory Viruses, Hospices Civils de Lyon, Université Claude Bernard Lyon1, Lyon, France. Dimopoulou Dimitra D European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Second Department of Paediatrics, "P. and A. Kyriakou" Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece. Dimopoulou Konstantina K Department of Gastroenterology, Hippokration General Hospital of Athens, Athens, Greece. Zelli Silvia S Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy. de Salazar Adolfo A Servicio de Microbiología Clínica, Hospital Universitario Clínico San Cecilio, Instituto de Investigación Biosanitaria, Ibs. Granada, Granada, Spain; Centro de Investigación Biomédicaen Red Enfermedades Infecciosas (CIBERINFEC), ISCIII, Madrid, Spain. Reiter Rieke R Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Janocha Hannah H Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Grossi Adriano A Local Health Authority ASL Roma 1, Rome, Italy. Omony Jimmy J Institute for Asthma and Allergy Prevention (IAP), Helmholtz Zentrum Munich, German Research Centre for Environmental Health (GmbH), Munich, Germany. Skevaki Chrysanthi C European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV), Greece; Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Centre (UGMLC), Philipps University Marburg, German Centre for Lung Research (DZL), Marburg, Germany. Electronic address: chrysanthi.skevaki@uk-gm.de. eng Journal Article 2023 04 22 England Clin Microbiol Infect 9516420 1198-743X IM Humans COVID-19 diagnosis SARS-CoV-2 Communicable Diseases Diagnostic Techniques and Procedures COVID-19 Testing COVID-19 Diagnosis Guidelines SARS-CoV-2 Testing 2023 2 1 2023 4 13 2023 4 16 2023 6 19 13 9 2023 4 24 0 41 2023 4 23 19 35 2023 4 22 ppublish 37088423 PMC10122552 10.1016/j.cmi.2023.04.019 S1198-743X(23)00192-1 Fragkou P.C., De Angelis G., Menchinelli G., Can F., Garcia F., Morfin-Sherpa F., et al. ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2. Clin Microbiol Infect. 2022;28:812–822. doi: 10.1016/J.CMI.2022.02.011. 10.1016/J.CMI.2022.02.011 PMC8863949 35218978 Brümmer L.E., Katzenschlager S., McGrath S., Schmitz S., Gaeddert M., Erdmann C., et al. Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: an updated systematic review and meta-analysis with meta-regression analyzing influencing factors. PLOS Med. 2022;19 doi: 10.1371/JOURNAL.PMED.1004011. 10.1371/JOURNAL.PMED.1004011 PMC9187092 35617375 Goupil-Sormany I., Longtin J., Dumaresq J., Jacob-Wagner M., Bouchard F., Romero L., et al. The PRONTO study: clinical performance of ID NOW in individuals with compatible SARS-CoV-2 symptoms in walk-in centres-accelerated turnaround time for contact tracing. Can Commun Dis Rep. 2021;47:534–542. doi: 10.14745/CCDR.V47I12A04. 10.14745/CCDR.V47I12A04 PMC8699396 35018141 Houston H., Gupta-Wright A., Toke-Bjolgerud E., Biggin-Lamming J., John L. Diagnostic accuracy and utility of SARS-CoV-2 antigen lateral flow assays in medical admissions with possible COVID-19. J Hosp Infect. 2021;110:203–205. doi: 10.1016/J.JHIN.2021.01.018. 10.1016/J.JHIN.2021.01.018 PMC7848576 33539935 Jung C., Levy C., Varon E., Biscardi S., Batard C., Wollner A., et al. Diagnostic accuracy of SARS-CoV-2 antigen detection test in children: a real-life study. Front Pediatr. 2021;9 doi: 10.3389/FPED.2021.647274. 10.3389/FPED.2021.647274 PMC8321236 34336732 Kritikos A., Caruana G., Brouillet R., Miroz J.P., Abed-Maillard S., Stieger G., et al. Sensitivity of rapid antigen testing and RT-PCR performed on nasopharyngeal swabs versus saliva samples in COVID-19 hospitalized patients: results of a Prospective Comparative Trial (RESTART) Microorganisms. 2021;9:1910. doi: 10.3390/MICROORGANISMS9091910. 10.3390/MICROORGANISMS9091910 PMC8464722 34576805 Nagura-Ikeda M., Imai K., Tabata S., Miyoshi K., Murahara N., Mizuno T., et al. Clinical evaluation of self-collected saliva by quantitative reverse transcription-PCR (RT-qPCR), direct RT-qPCR, reverse transcription-loop-mediated isothermal amplification, and a rapid antigen test to diagnose COVID-19. J Clin Microbiol. 2020;58 doi: 10.1128/JCM.01438-20. e01438–20. 10.1128/JCM.01438-20 PMC7448663 32636214 Nomoto H., Yamamoto K., Yamada G., Suzuki M., Kinoshita N., Takasaki J., et al. Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: the potential contribution to alleviating isolation of COVID-19 patients. J Infect Chemother. 2021;27:1669–1673. doi: 10.1016/J.JIAC.2021.08.015. 10.1016/J.JIAC.2021.08.015 PMC8363432 34454833 Shaikh N., Friedlander E.J., Tate P.J., Liu H., Chang C.C.H., Wells A., et al. Performance of a rapid SARS-CoV-2 antigen detection assay in symptomatic children. Pediatrics. 2021;148 doi: 10.1542/PEDS.2021-050832. 10.1542/PEDS.2021-050832 34039718 Shidlovskaya E.V., Kuznetsova N.A., Divisenko E.V., Nikiforova M.A., Siniavin A.E., Ogarkova D.A., et al. The value of rapid antigen tests for identifying carriers of viable SARS-CoV-2. Viruses. 2021;13:2012. doi: 10.3390/V13102012. 10.3390/V13102012 PMC8537476 34696442 Abdul-Mumin A., Abubakari A., Agbozo F., Abdul-Karim A., Nuertey B.D., Mumuni K., et al. Field evaluation of specificity and sensitivity of a standard SARS-CoV-2 antigen rapid diagnostic test: a prospective study at a teaching hospital in Northern Ghana. MedRxiv. 2021:2021. doi: 10.1101/2021.06.03.21258300. 10.1101/2021.06.03.21258300 PMC10021174 36962111 Adnan N., Khandker S.S., Haq A., Chaity M.A., Khalek A., Nazim A.Q., et al. Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition. Expert Rev Anti Infect Ther. 2022;20:473–481. doi: 10.1080/14787210.2021.1976144. 10.1080/14787210.2021.1976144 PMC8442762 34477019 Akingba O.L., Sprong K., Marais G., Hardie D.R. Field performance evaluation of the PanBio rapid SARS-CoV-2 antigen assay in an epidemic driven by the B.1.351 variant in the Eastern Cape, South Africa. J Clin Virol Plus. 2021;1 doi: 10.1016/J.JCVP.2021.100013. 10.1016/J.JCVP.2021.100013 PMC8025602 35262001 Albert E., Torres I., Bueno F., Huntley D., Molla E., Fernández-Fuentes M.Á., et al. Field evaluation of a rapid antigen test (PanBioTM COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres. Clin Microbiol Infect. 2021;27:472.e7–472.e10. doi: 10.1016/J.CMI.2020.11.004. 10.1016/J.CMI.2020.11.004 PMC7662075 33189872 Alemany A., Baró B., Ouchi D., Rodó P., Ubals M., Corbacho-Monné M., et al. Analytical and clinical performance of the PanBio COVID-19 antigen-detecting rapid diagnostic test. J Infect. 2021;82:186–230. doi: 10.1016/J.JINF.2020.12.033. 10.1016/J.JINF.2020.12.033 PMC7788317 33421447 Aoki K., Nagasawa T., Ishii Y., Yagi S., Kashiwagi K., Miyazaki T., et al. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2. J Infect Chemother. 2021;27:319–322. doi: 10.1016/J.JIAC.2020.11.015. 10.1016/J.JIAC.2020.11.015 PMC7757343 33388232 Bachman C.M., Grant B.D., Anderson C.E., Alonzo L.F., Garing S., Byrnes S.A., et al. Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0256352. 10.1371/JOURNAL.PONE.0256352 PMC8370603 34403456 Bianco G., Boattini M., Barbui A.M., Scozzari G., Riccardini F., Coggiola M., et al. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021;139 doi: 10.1016/J.JCV.2021.104838. 10.1016/J.JCV.2021.104838 PMC8058048 33946040 Boum Y., Fai K.N., Nikolay B., Mboringong A.B., Bebell L.M., Ndifon M., et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. Lancet Infect Dis. 2021;21:1089–1096. doi: 10.1016/S1473-3099(21)00132-8. 10.1016/S1473-3099(21)00132-8 PMC7993929 33773618 Bulilete O., Lorente P., Leiva A., Carandell E., Oliver A., Rojo E., et al. Evaluation of the PanBioTM rapid antigen test for SARS-CoV-2 in primary health care centers and test sites. MedRxiv. 2020:2020. doi: 10.1101/2020.11.13.20231316. 10.1101/2020.11.13.20231316 de O Cardoso J.M., Roatt B.M., de A Vieira P.M., de Paiva N.C.N., Bernardes-Souza B., Lisboa O.C., et al. Performance of the Wondfo 2019-nCoV antigen test using self-collected nasal versus professional-collected nasopharyngeal swabs in symptomatic SARS-CoV-2 infection. Diagnosis (Berl) 2022;9:398–402. doi: 10.1515/DX-2022-0003. 10.1515/DX-2022-0003 35285222 Caruana G., Croxatto A., Kampouri E., Kritikos A., Opota O., Foerster M., et al. Implementing SARS-CoV-2 rapid antigen testing in the emergency ward of a Swiss University Hospital: the INCREASE Study. Microorganisms. 2021;9:798. doi: 10.3390/MICROORGANISMS9040798. 10.3390/MICROORGANISMS9040798 PMC8069749 33920307 Cerutti F., Burdino E., Milia M.G., Allice T., Gregori G., Bruzzone B., et al. Urgent need of rapid tests for SARS CoV-2 antigen detection: evaluation of the SD-Biosensor antigen test for SARS-CoV-2. J Clin Virol. 2020;132 doi: 10.1016/J.JCV.2020.104654. 10.1016/J.JCV.2020.104654 PMC7522649 33053494 Courtellemont L., Guinard J., Guillaume C., Giaché S., Rzepecki V., Seve A., et al. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection. J Med Virol. 2021;93:3152–3157. doi: 10.1002/JMV.26896. 10.1002/JMV.26896 PMC8014580 33615487 Deslandes V., Clark E., Thiruganasambandamoorthy V., Desjardins M. Implementation of the Abbott ID Now COVID-19 assay at a tertiary care center: a prospective pragmatic implementation study during the third wave of SARS-CoV-2 in Ontario. Diagn Microbiol Infect Dis. 2022;102 doi: 10.1016/J.DIAGMICROBIO.2021.115609. 10.1016/J.DIAGMICROBIO.2021.115609 PMC8626348 34933188 Drain P.K., Ampajwala M., Chappel C., Gvozden A.B., Hoppers M., Wang M., et al. A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care: a clinical performance study. Infect Dis Ther. 2021;10:753–761. doi: 10.1007/S40121-021-00413-X. 10.1007/S40121-021-00413-X PMC7904038 33629225 Drevinek P., Hurych J., Kepka Z., Briksi A., Kulich M., Zajac M., et al. The sensitivity of SARS-CoV-2 antigen tests in the view of large-scale testing. MedRxiv. 2020:2020. doi: 10.1101/2020.11.23.20237198. 10.1101/2020.11.23.20237198 34641689 Eleftheriou I., Dasoula F., Dimopoulou D., Lebessi E., Serafi E., Spyridis N., et al. Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children. J Med Virol. 2021;93:6040–6044. doi: 10.1002/JMV.27149. 10.1002/JMV.27149 PMC8427014 34156112 Elli S., Blasi F., Brignolo B., Ceriotti F., Gori A., Piatti A., et al. Diagnostic accuracy of rapid antigen test for COVID-19 in an emergency department. Diagn Microbiol Infect Dis. 2022;102 doi: 10.1016/J.DIAGMICROBIO.2022.115635. 10.1016/J.DIAGMICROBIO.2022.115635 PMC8761115 35216863 Farhana A., Zahoor D., Wani S., Khan R.A., Nasir R., Kanth F. Diagnostic utility and performance of rapid antigen test in SARS CoV-2 in symptomatic and asymptomatic patients during the second pandemic wave in Kashmir, North India. Indian J Med Microbiol. 2022;40:572–576. doi: 10.1016/J.IJMMB.2022.06.007. 10.1016/J.IJMMB.2022.06.007 PMC9249411 35787334 Fenollar F., Bouam A., Ballouche M., Fuster L., Prudent E., Colson P., et al. Evaluation of the PanBio COVID-19 rapid antigen detection test device for the screening of patients with COVID-19. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.02589-20. e02589–20. 10.1128/JCM.02589-20 PMC8111145 33139420 Filgueiras P.S., Corsini C.A., Almeida N.B., Assis J.V., Luysa M., Pedrosa C., et al. COVID-19 rapid antigen test at hospital admission associated to the knowledge of individual risk factors allow overcoming the difficulty of managing suspected patients in hospitals COVID-19 rapid antigen test facilitates the management of suspected patients on hospital admission. MedRxiv. 2021:2021. doi: 10.1101/2021.01.06.21249282. 10.1101/2021.01.06.21249282 Foundation for Innovative New Diagnostics (FIND) COVID-19 test directory – FIND. https://www.finddx.org/tools-and-resources/dxconnect/test-directories/covid-19-test-directory/ n.d. Fitoussi F., Tonen-Wolyec S., Awaida N., Dupont R., Bélec L. Analytical performance of the point-of-care BIOSYNEX COVID-19 Ag BSS for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective field evaluation during the COVID-19 third wave in France. Infection. 2022;50:625–633. doi: 10.1007/S15010-021-01723-5. 10.1007/S15010-021-01723-5 PMC8542359 34689310 Fourati S, Audureau É, Chevaliez S, Pawlotsky J-M. Évaluation de la performance diagnostique des tests rapides d’orientation diagnostique antigéniques COVID-19. n.d. https://www.calameo.com/read/004021827da342e75785b?utm_source=platform&utm_medium=email&utm_campaign=book_created&utm_content=html&utm_term=4021827 [Accessed 15 August 2022]. Frediani J.K., Levy J.M., Rao A., Bassit L., Figueroa J., Vos M.B., et al. Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration. Sci Rep. 2021;11 doi: 10.1038/S41598-021-94055-1. 10.1038/S41598-021-94055-1 PMC8285474 34272449 Freire M.L., Alves L.L., de Souza C.S., Saliba J.W., Faria V., Pedras M.J., et al. Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil. PLOS ONE. 2022;17 doi: 10.1371/JOURNAL.PONE.0269997. 10.1371/JOURNAL.PONE.0269997 PMC9202877 35709075 Garcia-Cardenas F., Peñaloza F., Bertin-Montoya J., Valdéz-Vázquez R., Franco A., Cortés R., et al. Analytical performances of the COVISTIXTM antigen rapid test for SARS-CoV-2 detection in an unselected population (all-comers) Pathogens. 2022;11:628. doi: 10.3390/PATHOGENS11060628. 10.3390/PATHOGENS11060628 PMC9229999 35745482 González-Donapetry P., García-Clemente P., Bloise I., García-Sánchez C., Sánchez Castellano M.Á., Romero M.P., et al. Think of the children: evaluation of SARS-CoV-2 rapid antigen test in pediatric population. Pediatr Infect Dis J. 2021;40:385–388. doi: 10.1097/INF.0000000000003101. 10.1097/INF.0000000000003101 33605674 Gupta A., Khurana S., Das R., Srigyan D., Singh A., Mittal A., et al. Rapid chromatographic immunoassay-based evaluation of COVID-19: a cross-sectional, diagnostic test accuracy study & its implications for COVID-19 management in India. Indian J Med Res. 2021;153:126–131. doi: 10.4103/IJMR.IJMR_3305_20. 10.4103/IJMR.IJMR_3305_20 PMC8184078 33818469 Halfon P., Penaranda G., Khiri H., Garcia V., Drouet H., Philibert P., et al. An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0257817. 10.1371/JOURNAL.PONE.0257817 PMC8460002 34555117 Harris D.T., Badowski M., Jernigan B., Sprissler R., Edwards T., Cohen R., et al. SARS-CoV-2 rapid antigen testing of symptomatic and asymptomatic individuals on the University of Arizona Campus. Biomedicines. 2021;9:539. doi: 10.3390/BIOMEDICINES9050539. 10.3390/BIOMEDICINES9050539 PMC8150898 34066047 Ifko M., Skvarc M. Use of immunochromatographic SARS-CoV-2 antigen testing in eight long-term care facilities for the elderly. Healthcare (Basel) 2021;9:868. doi: 10.3390/HEALTHCARE9070868. 10.3390/HEALTHCARE9070868 PMC8307499 34356246 Jegerlehner S., Suter-Riniker F., Jent P., Bittel P., Nagler M. Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings. Int J Infect Dis. 2021;109:118–122. doi: 10.1016/J.IJID.2021.07.010. 10.1016/J.IJID.2021.07.010 PMC8260496 34242764 Johnson C., Ferguson K., Smith T., Wallace D., McConnell K., Conserve D., et al. Evaluation of the PanBio SARS-CoV-2 rapid antigen detection test in the Bahamas. MedRxiv. 2021:2021. doi: 10.1101/2021.07.13.21260402. 10.1101/2021.07.13.21260402 Karuga I., Munyua P., Ochieng C., Juma B., Amoth P., Kuria F., et al. Diagnostic accuracy of the PanBioTM COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: a field evaluation. MedRxiv. 2022:2022. doi: 10.1101/2022.05.23.22275439. 10.1101/2022.05.23.22275439 PMC9876661 36696882 Kernéis S., Elie C., Fourgeaud J., Choupeaux L., Delarue S.M., Alby M.L., et al. Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study. Eur J Clin Microbiol Infect Dis. 2021;40:2379–2388. doi: 10.1007/S10096-021-04327-X. 10.1007/S10096-021-04327-X PMC8329409 34342768 Kim H.W., Park M., Lee J.H. Clinical evaluation of the rapid STANDARD Q COVID-19 Ag test for the screening of severe acute respiratory syndrome coronavirus 2. Ann Lab Med. 2022;42:100–104. doi: 10.3343/ALM.2022.42.1.100. 10.3343/ALM.2022.42.1.100 PMC8368224 34374355 King C., Weever E.L., Henry M., Steingrover R., Fleming C., Panneflek R., et al. Validation of the PanBioTM COVID-19 antigen rapid test (Abbott) to screen for SARS-CoV-2 infection in Sint Maarten: a diagnostic accuracy study. MedRxiv. 2021:2021. doi: 10.1101/2021.09.23.21260526. 10.1101/2021.09.23.21260526 Kiyasu Y., Takeuchi Y., Akashi Y., Kato D., Kuwahara M., Muramatsu S., et al. Prospective analytical performance evaluation of the QuickNaviTM-COVID19 Ag for asymptomatic individuals. J Infect Chemother. 2021;27:1489–1492. doi: 10.1016/J.JIAC.2021.07.005. 10.1016/J.JIAC.2021.07.005 PMC8266545 34301485 Klajmon A., Olechowska-Jarząb A., Salamon D., Sroka-Oleksiak A., Brzychczy-Włoch M., Gosiewski T. Comparison of antigen tests and qPCR in rapid diagnostics of infections caused by SARS-CoV-2 virus. Viruses. 2021;14:17. doi: 10.3390/V14010017. 10.3390/V14010017 PMC8779007 35062221 Koeleman J.G.M., Brand H., de Man S.J., Ong D.S.Y. Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40:1975–1981. doi: 10.1007/S10096-021-04274-7. 10.1007/S10096-021-04274-7 PMC8140309 34021840 Kolwijck E., Brouwers-Boers M., Broertjes J., van Heeswijk K., Runderkamp N., Meijer A., et al. Validation and implementation of the PanBio COVID-19 Ag rapid test for the diagnosis of SARS-CoV-2 infection in symptomatic hospital healthcare workers. Infect Prev Pract. 2021;3 doi: 10.1016/J.INFPIP.2021.100142. 10.1016/J.INFPIP.2021.100142 PMC8050397 34316580 Korenkov M., Poopalasingam N., Madler M., Vanshylla K., Eggeling R., Wirtz M., et al. Assessment of SARS-CoV-2 infectivity by a rapid antigen detection test. MedRxiv. 2021:2021. doi: 10.1101/2021.03.30.21254624. 10.1101/2021.03.30.21254624 Krüger L.J., Gaeddert M., Tobian F., Lainati F., Gottschalk C., Klein J.A.F., et al. The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-evaluation of the accuracy and ease-of-use. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0247918. 10.1371/JOURNAL.PONE.0247918 PMC8158996 34043631 Kurihara Y., Kiyasu Y., Akashi Y., Takeuchi Y., Narahara K., Mori S., et al. The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2. J Infect Chemother. 2021;27:1493–1497. doi: 10.1016/J.JIAC.2021.07.006. 10.1016/J.JIAC.2021.07.006 PMC8275475 34294528 L’Huillier A.G., Lacour M., Sadiku D., Gadiri M.A., De Siebenthal L., Schibler M., et al. Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00991-21. 10.1128/JCM.00991-21 PMC8373030 34190574 Landaas E.T., Storm M.L., Tollånes M.C., Barlinn R., Kran A.M.B., Bragstad K., et al. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. J Clin Virol. 2021;137 doi: 10.1016/J.JCV.2021.104789. 10.1016/J.JCV.2021.104789 PMC7944803 33736946 Leber W., Lammel O., Siebenhofer A., Redlberger-Fritz M., Panovska-Griffiths J., Czypionka T. Comparing the diagnostic accuracy of point-of-care lateral flow antigen testing for SARS-CoV-2 with RT-PCR in primary care (REAP-2) EClinicalMedicine. 2021;38 doi: 10.1016/J.ECLINM.2021.101011. 10.1016/J.ECLINM.2021.101011 PMC8277224 34278276 Linares M., Pérez-Tanoira R., Carrero A., Romanyk J., Pérez-García F., Gómez-Herruz P., et al. PanBio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J Clin Virol. 2020;133 doi: 10.1016/J.JCV.2020.104659. 10.1016/J.JCV.2020.104659 PMC7561603 33160179 Lindner A.K., Nikolai O., Kausch F., Wintel M., Hommes F., Gertler M., et al. Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Eur Respir J. 2021;57 doi: 10.1183/13993003.03961-2020. 10.1183/13993003.03961-2020 PMC7736752 33303544 Lindner A.K., Nikolai O., Rohardt C., Kausch F., Wintel M., Gertler M., et al. Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test. J Clin Virol. 2021;141 doi: 10.1016/J.JCV.2021.104874. 10.1016/J.JCV.2021.104874 PMC8163726 34144452 Lunca C., Cojocaru C., Gurzu I.L., Petrariu F.D., Cojocaru E. Performance of antigenic detection of SARS-CoV-2 in nasopharyngeal samples. MedRxiv. 2021:2021. doi: 10.1101/2021.07.12.21260263. 10.1101/2021.07.12.21260263 Lv Y., Ma Y., Si Y., Zhu X., Zhang L., Feng H., et al. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease. Biosci Trends. 2021;15:93–99. doi: 10.5582/BST.2021.01090. 10.5582/BST.2021.01090 33776018 Masiá M., Fernández-González M., Sánchez M., Carvajal M., García J.A., Gonzalo-Jiménez N., et al. Nasopharyngeal PanBio COVID-19 antigen performed at point-of-care has a high sensitivity in symptomatic and asymptomatic patients with higher risk for transmission and older age. Open Forum Infect Dis. 2021;8:ofab059. doi: 10.1093/OFID/OFAB059. 10.1093/OFID/OFAB059 PMC7928615 33723512 Mboumba Bouassa R.S., Veyer D., Péré H., Bélec L. Analytical performances of the point-of-care SIENNATM COVID-19 antigen rapid test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: a prospective evaluation during the COVID-19 second wave in France. Int J Infect Dis. 2021;106:8–12. doi: 10.1016/J.IJID.2021.03.051. 10.1016/J.IJID.2021.03.051 PMC7970753 33746093 Menchinelli G., De Angelis G., Cacaci M., Liotti F.M., Candelli M., Palucci I., et al. SARS-CoV-2 antigen detection to expand testing capacity for COVID-19: results from a hospital emergency department testing site. Diagnostics (Basel) 2021;11:1211. doi: 10.3390/DIAGNOSTICS11071211. 10.3390/DIAGNOSTICS11071211 PMC8304665 34359294 Merino P., Guinea J., Muñoz-Gallego I., González-Donapetry P., Galán J.C., Antona N., et al. Multicenter evaluation of the PanBioTM COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect. 2021;27:758–761. doi: 10.1016/J.CMI.2021.02.001. 10.1016/J.CMI.2021.02.001 PMC7884234 33601009 Mertens P., De Vos N., Martiny D., Jassoy C., Mirazimi A., Cuypers L., et al. Development and potential usefulness of the COVID-19 Ag Respi-Strip diagnostic assay in a pandemic context. Front Med (Lausanne) 2020;7:225. doi: 10.3389/FMED.2020.00225. 10.3389/FMED.2020.00225 PMC7227790 32574326 Micocci M., Buckle P., Hayward G., Allen A.J., Davies K., Kierkegaard P., et al. Point of care testing using rapid automated antigen testing for SARS-COV-2 in care homes – an exploratory safety, usability and diagnostic agreement evaluation. MedRxiv. 2021:2021. doi: 10.1101/2021.04.22.21255948. 10.1101/2021.04.22.21255948 Mirahmadizadeh A., Yeganeh B.S., Hassanzadeh J., Badiee L., Vali M., Maleki Z., et al. Value of rapid antigen test in comparison with reverse transcriptase-polymerase chain reaction method in the diagnosis of COVID-19. Mediterr J Infect Microbe Antimicrob. 2022;11 doi: 10.4274/MJIMA.GALENOS.2021.2021.2. 10.4274/MJIMA.GALENOS.2021.2021.2 Möckel M., Corman V.M., Stegemann M.S., Hofmann J., Stein A., Jones T.C., et al. SARS-CoV-2 antigen rapid immunoassay for diagnosis of COVID-19 in the emergency department. Biomarkers. 2021;26:213–220. doi: 10.1080/1354750X.2021.1876769. 10.1080/1354750X.2021.1876769 PMC7898296 33455451 Moraleda C., Domínguez-Rodríguez S., Mesa J.M., García-Sánchez P., De La Serna M., Alonso-Cadenas J.A., et al. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population. Arch Dis Child. 2022;107:1051–1058. doi: 10.1136/ARCHDISCHILD-2021-323712. 10.1136/ARCHDISCHILD-2021-323712 35688603 Nordgren J., Sharma S., Olsson H., Jämtberg M., Falkeborn T., Svensson L., et al. SARS-CoV-2 rapid antigen test: high sensitivity to detect infectious virus. J Clin Virol. 2021;140 doi: 10.1016/J.JCV.2021.104846. 10.1016/J.JCV.2021.104846 PMC8105081 33971580 Orsi A., Pennati B.M., Bruzzone B., Ricucci V., Ferone D., Barbera P., et al. On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic. J Virol Methods. 2021;295 doi: 10.1016/J.JVIROMET.2021.114201. 10.1016/J.JVIROMET.2021.114201 PMC8161776 34058287 Pérez-García F., Romanyk J., Gómez-Herruz P., Arroyo T., Pérez-Tanoira R., Linares M., et al. Diagnostic performance of CerTest and PanBio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. J Clin Virol. 2021;137 doi: 10.1016/J.JCV.2021.104781. 10.1016/J.JCV.2021.104781 PMC7897407 33639492 Pandey A.K., Mohanty A., Hada V., Rath R.S., Kumar S., Kishore S., et al. Comparison of the rapid antigen testing method with RT-qPCR for the diagnosis of COVID-19. Cureus. 2021;13 doi: 10.7759/CUREUS.17405. 10.7759/CUREUS.17405 PMC8459390 34589316 Porte L., Legarraga P., Iruretagoyena M., Vollrath V., Munita J.M., Araos R., et al. Rapid SARS-CoV-2 antigen detection by immunofluorescence-a new tool to detect 1 infectivity 2 3. Medrvix. 2020 doi: 10.1101/2020.10.04.20206466. 10.1101/2020.10.04.20206466 Porte L., Legarraga P., Vollrath V., Aguilera X., Munita J.M., Araos R., et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Int J Infect Dis. 2020;99:328–333. doi: 10.1016/J.IJID.2020.05.098. 10.1016/J.IJID.2020.05.098 PMC7263236 32497809 Ptasinska A., Whalley C., Bosworth A., Poxon C., Bryer C., Machin N., et al. Diagnostic accuracy of loop-mediated isothermal amplification coupled to nanopore sequencing (LamPORE) for the detection of SARS-CoV-2 infection at scale in symptomatic and asymptomatic populations. Clin Microbiol Infect. 2021;27:1348.e1–1348.e7. doi: 10.1016/J.CMI.2021.04.008. 10.1016/J.CMI.2021.04.008 PMC8064897 33901668 Regev-Yochay G., Kriger O., Mina M.J., Beni S., Rubin C., Mechnik B., et al. Real world performance of SARS-CoV-2 antigen rapid diagnostic tests in various clinical settings. Infect Control Hosp Epidemiol. 2022:1–20. doi: 10.1017/ICE.2022.3. 10.1017/ICE.2022.3 35232504 Ristić M., Nikolić N., Čabarkapa V., Turkulov V., Petrović V. Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0247606. 10.1371/JOURNAL.PONE.0247606 PMC7899368 33617597 Robinson M.L., Mirza A., Gallagher N., Boudreau A., Jacinto L.G., Yu T., et al. Limitations of molecular and antigen test performance for SARS-CoV-2 in symptomatic and asymptomatic COVID-19 contacts. J Clin Microbiol. 2022;60 doi: 10.1128/jcm.00187-22. 10.1128/jcm.00187-22 PMC9297839 35730949 Rohde J., Himmel W., Hofinger C., Lâm T.-T., Schrader H., Wallstabe J., et al. Diagnostic accuracy and feasibility of a rapid SARS-CoV-2 antigen test in general practice-a prospective multicenter validation and implementation study. BMC Prim Care. 2022;23:149. doi: 10.1186/s12875-022-01756-1. 10.1186/s12875-022-01756-1 PMC9187884 35690722 Schwob J.M., Miauton A., Petrovic D., Perdrix J., Senn N., Jaton K., et al. Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: a prospective comparative clinical trial. MedRxiv. 2020:2020. doi: 10.1101/2020.11.23.20237057. 10.1101/2020.11.23.20237057 PMC9955963 36827328 Scohy A., Anantharajah A., Bodéus M., Kabamba-Mukadi B., Verroken A., Rodriguez-Villalobos H. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129 doi: 10.1016/J.JCV.2020.104455. 10.1016/J.JCV.2020.104455 PMC7240272 32485618 Smith R.D., Johnson J.K., Clay C., Girio-Herrera L., Stevens D., Abraham M., et al. Clinical evaluation of Sofia Rapid Antigen Assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among emergency department to hospital admissions. Infect Control Hosp Epidemiol. 2022;43:968–973. doi: 10.1017/ICE.2021.281. 10.1017/ICE.2021.281 PMC8376850 34162449 Stokes W., Berenger B.M., Portnoy D., Scott B., Szelewicki J., Singh T., et al. Clinical performance of the Abbott PanBio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Eur J Clin Microbiol Infect Dis. 2021;40:1721–1726. doi: 10.1007/S10096-021-04202-9. 10.1007/S10096-021-04202-9 PMC7979467 33742322 Suzuki H., Akashi Y., Kato D., Takeuchi Y., Kiyasu Y., Terada N., et al. Analytical performance of the rapid qualitative antigen kit for the detection of SARS-CoV-2 during widespread circulation of the Omicron variant. J Infect Chemother. 2023;29:257–262. doi: 10.1016/J.JIAC.2022.11.006. 10.1016/J.JIAC.2022.11.006 PMC9675935 36417995 Suzuki H., Akashi Y., Ueda A., Kiyasu Y., Takeuchi Y., Maehara Y., et al. Diagnostic performance of a novel digital immunoassay (RapidTesta SARS-CoV-2): a prospective observational study with nasopharyngeal samples. J Infect Chemother. 2022;28:78–81. doi: 10.1016/J.JIAC.2021.10.024. 10.1016/J.JIAC.2021.10.024 PMC8549190 34736814 Takeuchi Y., Akashi Y., Kato D., Kuwahara M., Muramatsu S., Ueda A., et al. Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study. Sci Rep. 2021;11 doi: 10.1038/S41598-021-90026-8. 10.1038/S41598-021-90026-8 PMC8131686 34006975 Takeuchi Y., Akashi Y., Kato D., Kuwahara M., Muramatsu S., Ueda A., et al. The evaluation of a newly developed antigen test (QuickNaviTM-COVID19 Ag) for SARS-CoV-2: a prospective observational study in Japan. J Infect Chemother. 2021;27:890–894. doi: 10.1016/J.JIAC.2021.02.029. 10.1016/J.JIAC.2021.02.029 PMC7931724 33727026 Terpos E., Ntanasis-Stathopoulos I., Skvarč M. Clinical application of a new SARS-CoV-2 antigen detection kit (colloidal gold) in the detection of COVID-19. Diagnostics (Basel) 2021;11:995. doi: 10.3390/DIAGNOSTICS11060995. 10.3390/DIAGNOSTICS11060995 PMC8229208 34070844 Thirion-Romero I., Guerrero-Zúñiga D.S., Arias-Mendoza D.A., Cornejo-Juárez D.D.P., Meza-Meneses D.P., Torres-Erazo D.D.S., et al. Evaluation of PanBio rapid antigen test for SARS-CoV-2 in symptomatic patients and their contacts: a multicenter study. Int J Infect Dis. 2021;113:218–224. doi: 10.1016/J.IJID.2021.10.027. 10.1016/J.IJID.2021.10.027 PMC8526115 34678504 Thommes L., Burkert F.R., Öttl K.W., Goldin D., Loacker L., Lanser L., et al. Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients. Int J Infect Dis. 2021;105:144–146. doi: 10.1016/J.IJID.2021.02.052. 10.1016/J.IJID.2021.02.052 PMC7888994 33609774 Torres I., Poujois S., Albert E., Álvarez G., Colomina J., Navarro D. Point-of-care evaluation of a rapid antigen test (CLINITEST® Rapid COVID-19 Antigen Test) for diagnosis of SARS-CoV-2 infection in symptomatic and asymptomatic individuals. J Infect. 2021;82:e11–e12. doi: 10.1016/J.JINF.2021.02.010. 10.1016/J.JINF.2021.02.010 PMC7879056 33587922 de Michelena P., Torres I., Ramos-García Á, Gosalbes V., Ruiz N., Sanmartín A., et al. Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant. MedRxiv. 2022:2022. doi: 10.1101/2022.02.02.22270295. 10.1101/2022.02.02.22270295 PMC8863328 35217106 Tsai S.C., Lee W.S., Chen P.Y., Hung S.H. Real world clinical performance of SARS-CoV-2 rapid antigen tests in suspected COVID-19 cases in Taiwan. J Formos Med Assoc. 2021;120:2042–2043. doi: 10.1016/J.JFMA.2021.07.011. 10.1016/J.JFMA.2021.07.011 PMC8275487 34301424 Venekamp R.P., Veldhuijzen I.K., Moons K.G.M., van den Bijllaardt W., Pas S.D., Lodder E.B., et al. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study. BMC Med. 2022;20:1–13. doi: 10.1186/S12916-022-02300-9/TABLES/3. 10.1186/S12916-022-02300-9/TABLES/3 PMC8866040 35197052 Veyrenche N., Bolloré K., Pisoni A., Bedin A.S., Mondain A.M., Ducos J., et al. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission. J Med Virol. 2021;93:3069–3076. doi: 10.1002/JMV.26855. 10.1002/JMV.26855 PMC8013599 33554363 Villaverde S., Domínguez-Rodríguez S., Sabrido G., Pérez-Jorge C., Plata M., Romero M.P., et al. Diagnostic accuracy of the PanBio SARS-CoV-2 antigen rapid test compared with Rt-Pcr testing of nasopharyngeal samples in the pediatric population. J Pediatr. 2021;232:287–289. doi: 10.1016/J.JPEDS.2021.01.027. e4. 10.1016/J.JPEDS.2021.01.027 PMC7826137 33484697 Weitzel T., Legarraga P., Iruretagoyena M., Pizarro G., Vollrath V., Araos R., et al. Comparative evaluation of four rapid SARS-CoV-2 antigen detection tests using universal transport medium. Travel Med Infect Dis. 2020;39 doi: 10.1016/J.TMAID.2020.101942. 10.1016/J.TMAID.2020.101942 PMC7708826 33278609 Yamamoto K., Suzuki M., Yamada G., Sudo T., Nomoto H., Kinoshita N., et al. Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission. Int J Infect Dis. 2021;104:65–72. doi: 10.1016/J.IJID.2020.12.079. 10.1016/J.IJID.2020.12.079 PMC7778366 33401037 Yin N., Debuysschere C., Decroly M., Bouazza F.Z., Collot V., Martin C., et al. SARS-CoV-2 diagnostic tests: algorithm and field evaluation from the near patient testing to the automated diagnostic platform. Front Med (Lausanne) 2021;8 doi: 10.3389/FMED.2021.650581. 10.3389/FMED.2021.650581 PMC8055843 33889587 Yokota I., Sakurazawa T., Sugita J., Iwasaki S., Yasuda K., Yamashita N., et al. Performance of qualitative and quantitative antigen tests for SARS-CoV-2 using saliva. Infect Dis Rep. 2021;13:742–747. doi: 10.3390/IDR13030069. 10.3390/IDR13030069 PMC8395849 34449650 Yokota I., Sakurazawa T., Sugita J., Iwasaki S., Yasuda K., Yamashita N., et al. Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva. MedRxiv. 2020:2020. doi: 10.1101/2020.11.06.20227363. 10.1101/2020.11.06.20227363 PMC8395849 34449650 Bond K.A., Smith B., Gardiner E., Liew K.C., Williams E., Walsham N., et al. Utility of SARS-CoV-2 rapid antigen testing for patient triage in the emergency department: a clinical implementation study in Melbourne, Australia. Lancet Reg Health West Pac. 2022;25 doi: 10.1016/J.LANWPC.2022.100486. 10.1016/J.LANWPC.2022.100486 PMC9150863 35655473 Christensen K., Ren H., Chen S., Cooper C.K., Young S. Clinical evaluation of BD VeritorTM SARS-CoV-2 and Flu A+B assay for point-of-care (POC) system. MedRxiv. 2021:2021. doi: 10.1101/2021.05.04.21256323. 10.1101/2021.05.04.21256323 PMC9045085 35412847 Drain P.K., Bemer M., Morton J.F., Dalmat R., Abdille H., Thomas K.K., et al. Accuracy of 2 rapid antigen tests during 3 phases of SARS-CoV-2 variants. JAMA Netw Open. 2022;5:E2228143. doi: 10.1001/JAMANETWORKOPEN.2022.28143. 10.1001/JAMANETWORKOPEN.2022.28143 PMC9403778 36001317 Ford L., Whaley M.J., Shah M.M., Salvatore P.P., Segaloff H.E., Delaney A., et al. Antigen test performance among children and adults at a SARS-CoV-2 community testing site. Pediatr Infect Dis J. 2021;10:1052–1061. doi: 10.1093/JPIDS/PIAB081. 10.1093/JPIDS/PIAB081 PMC8932441 34468732 James A.E., Gulley T., Kothari A., Holder K., Garner K., Patil N. Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees. Infect Control Hosp Epidemiol. 2022;43:99–101. doi: 10.1017/ICE.2021.20. 10.1017/ICE.2021.20 PMC7870908 33487197 Kahn M., Schuierer L., Bartenschlager C., Zellmer S., Frey R., Freitag M., et al. Performance of antigen testing for diagnosis of COVID-19: a direct comparison of a lateral flow device to nucleic acid amplification based tests. BMC Infect Dis. 2021;21:798. doi: 10.1186/S12879-021-06524-7. 10.1186/S12879-021-06524-7 PMC8354301 34376187 Jakobsen K.K., Schmidt Jensen J., Todsen T., Lippert F., Martel C.J.-M., Klokker M., et al. Detection of SARS-CoV-2 infection by rapid antigen test in comparison with RT-PCR in a public setting. MedRxiv. 2021:2021. doi: 10.1101/2021.01.22.21250042. 10.1101/2021.01.22.21250042 Mehta A., Spencer B., Garg A., Kalmorge P., Gonzalez R.A.O., Taussig K., et al. Performance of Gazelle COVID-19 point-of-care test for detection of nucleocapsid antigen from SARS-CoV-2. MedRxiv. 2022:2022. doi: 10.1101/2022.03.23.22272094. 10.1101/2022.03.23.22272094 Moritz E.D., McKay S.L., Tobolowsky F.A., Lavoie S.P., Waltenburg M.A., Lecy K.D., et al. Repeated antigen testing among severe acute respiratory coronavirus virus 2 (SARS-CoV-2)-positive nursing home residents. Infect Control Hosp Epidemiol. 2022;43:1918–1921. doi: 10.1017/ICE.2021.370. 10.1017/ICE.2021.370 PMC8712959 34412728 Nikolai O., Rohardt C., Tobian F., Junge A., Corman V.M., Jones T.C., et al. Anterior nasal versus nasal mid-turbinate sampling for a SARS-CoV-2 antigen-detecting rapid test: does localisation or professional collection matter? MedRxiv. 2021:2021. doi: 10.1101/2021.02.09.21251274. 10.1101/2021.02.09.21251274 PMC8425459 34445926 Olearo F., Nörz D., Heinrich F., Sutter J.P., Roedel K., Schultze A., et al. Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR. J Clin Virol. 2021;137 doi: 10.1016/J.JCV.2021.104782. 10.1016/J.JCV.2021.104782 PMC7927591 33711691 Parada-Ricart E., Gomez-Bertomeu F., Picó-Plana E., Olona-Cabases M. [Usefulness of the antigen for diagnosing SARS-CoV-2 infection in patients with and without symptoms] Enferm Infecc Microbiol Clin. 2021;39:357–358. doi: 10.1016/J.EIMC.2020.09.009. 10.1016/J.EIMC.2020.09.009 PMC8116129 34353515 Pollock N.R., Jacobs J.R., Tran K., Cranston A.E., Smith S., O’Kane C.Y., et al. Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00083-21. e00083–21. 10.1128/JCM.00083-21 PMC8091851 33622768 Pollock N.R., Tran K., Jacobs J.R., Cranston A.E., Smith S., O’Kane C.Y., et al. Performance and operational evaluation of the access Bio CareStart rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. Open Forum Infect Dis. 2021;8:ofab243. doi: 10.1093/OFID/OFAB243. 10.1093/OFID/OFAB243 PMC8244626 34250188 Pray I.W., Ford L., Cole D., Lee C., Bigouette J.P., Abedi G.R., et al. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses – Wisconsin, September-October 2020. MMWR Morb Mortal Wkly Rep. 2021;69:1642–1647. doi: 10.15585/MMWR.MM695152A3. 10.15585/MMWR.MM695152A3 PMC9191905 33382679 Salcedo N., Sena B.F., Qu X., Herrera B.B. Comparative evaluation of rapid isothermal amplification and antigen assays for screening testing of SARS-CoV-2. Viruses. 2022;14:468. doi: 10.3390/V14030468. 10.3390/V14030468 PMC8951466 35336875 Savage H.R., Finch L., Body R., Watkins R.L., Hayward G., Cook E., et al. A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing. PLOS ONE. 2022;17 doi: 10.1371/journal.pone.0270715. 10.1371/journal.pone.0270715 PMC9246218 35771760 Schildgen V., Demuth S., Lüsebrink J., Schildgen O. Limits and opportunities of SARS-CoV-2 antigen rapid tests: an experienced-based perspective. Pathogens. 2021;10:1–7. doi: 10.3390/PATHOGENS10010038. 10.3390/PATHOGENS10010038 PMC7824818 33466537 Schrom J., Marquez C., Pilarowski G., Wang C.Y., Mitchell A., Puccinelli R., et al. Comparison of SARS-CoV-2 reverse transcriptase polymerase chain reaction and BinaxNOW rapid antigen tests at a community site during an Omicron surge : a cross-sectional study. Ann Intern Med. 2022;175:682–690. doi: 10.7326/M22-0202. 10.7326/M22-0202 PMC8943844 35286144 Shah M.M., Salvatore P.P., Ford L., Kamitani E., Whaley M.J., Mitchell K., et al. Performance of repeat BinaxNOW severe acute respiratory syndrome coronavirus 2 antigen testing in a community setting, Wisconsin, November 2020-December 2020. Clin Infect Dis. 2021;73:S54–S57. doi: 10.1093/CID/CIAB309. 10.1093/CID/CIAB309 PMC8135465 33909068 Sood N., Shetgiri R., Rodriguez A., Jimenez D., Treminino S., Daflos A., et al. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: implications for screening in a school setting. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0249710. 10.1371/JOURNAL.PONE.0249710 PMC8021178 33819311 Sun K.J., Vaeth M.J.E., Robinson M., Elhabashy M., Gupta I., Purekal S., et al. High sensitivity and NPV for BinaxNOW rapid antigen test in children at a mass testing site during prevalent Delta variant period. Microbiol Spectr. 2022;10 doi: 10.1128/SPECTRUM.00236-22. 10.1128/SPECTRUM.00236-22 PMC9431243 35867409 Abdulrahman A., Mustafa F., AlAwadhi A.I., Alansari Q., AlAlawi B., AlQahtani M. Comparison of SARS-COV-2 nasal antigen test to nasopharyngeal RT-PCR in mildly symptomatic patients. MedRxiv. 2020 doi: 10.1101/2020.11.10.20228973. 10.1101/2020.11.10.20228973 Kawser Z., Hossain M., Suliman S., Lockman S., Gitaka J., Bandawe G., et al. An assessment of a rapid SARS-CoV-2 antigen test in Bangladesh. Am J Trop Med Hyg. 2022;107:845–849. doi: 10.4269/AJTMH.22-0068. 10.4269/AJTMH.22-0068 PMC9651516 35970285 Kilic A., Hiestand B., Palavecino E. Evaluation of performance of the BD Veritor SARS-CoV-2 chromatographic immunoassay test in patients with symptoms of COVID-19. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.00260-21. e00260–21. 10.1128/JCM.00260-21 PMC8091854 33637583 Medoro A., Davinelli S., Voccola S., Cardinale G., Passarella D., Marziliano N., et al. Assessment of the diagnostic performance of a novel SARS-CoV-2 antigen sealing tube test strip (colloidal gold) as point-of-care surveillance test. Diagnostics (Basel) 2022;12:1279. doi: 10.3390/DIAGNOSTICS12051279. 10.3390/DIAGNOSTICS12051279 PMC9141887 35626434 Pekosz A., Cooper C.K., Parvu V., Li M., Andrews J.C., Manabe Y.C., et al. Antigen-based testing but not real-time PCR correlates with SARS-CoV-2 virus culture. MedRxiv. 2020:2020. doi: 10.1101/2020.10.02.20205708. 10.1101/2020.10.02.20205708 Shin H., Lee S., Widyasari K., Yi J., Bae E., Kim S. Performance evaluation of STANDARD Q COVID-19 Ag home test for the diagnosis of COVID-19 during early symptom onset. J Clin Lab Anal. 2022;36 doi: 10.1002/JCLA.24410. 10.1002/JCLA.24410 PMC9110955 35441745 Van Der Moeren N., Zwart V.F., Van Esch H.R.J.M., Stohr J.J.J.M., Pas S.D., Kluytmans J.A.J.W. Performance evaluation of a SARS-CoV-2 rapid antigen test: test performance in the community in The Netherlands. MedRxiv. 2020:2020. doi: 10.1101/2020.10.19.20215202. 10.1101/2020.10.19.20215202 Young S., Taylor S.N., Cammarata C.L., Varnado K.G., Roger-Dalbert C., Montano A., et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS antigen point-of-care test. J Clin Microbiol. 2020;59 doi: 10.1128/JCM.02338-20. e02338–20. 10.1128/JCM.02338-20 PMC7771450 33023911 Amer R.M., Samir M., Gaber O.A., EL-Deeb N.A., Abdelmoaty A.A., Ahmed A.A., et al. Diagnostic performance of rapid antigen test for COVID-19 and the effect of viral load, sampling time, subject’s clinical and laboratory parameters on test accuracy. J Infect Public Health. 2021;14:1446–1453. doi: 10.1016/J.JIPH.2021.06.002. 10.1016/J.JIPH.2021.06.002 PMC8192262 34175237 Fatima A., Yaseen N., Fareed A., Samin K.A., Kanwal S., Qamar M. Role of COVID antigen in the diagnosis of COVID positive in obstetric patients. Pak J Med Health Sci. 2021;15:3356–3358. doi: 10.53350/PJMHS2115103356. 10.53350/PJMHS2115103356 Sicilia P., Castro G., Fantilli A.C., Gierotto R., López L., Barbás M.G., et al. Rapid screening of SARS-CoV-2 infection: good performance of nasopharyngeal and Nasal Mid-Turbinate swab for antigen detection among symptomatic and asymptomatic individuals. PLOS ONE. 2022;17 doi: 10.1371/JOURNAL.PONE.0266375. 10.1371/JOURNAL.PONE.0266375 PMC8986327 35363814 Thell R., Kallab V., Weinhappel W., Mueckstein W., Heschl L., Heschl M., et al. Evaluation of a novel, rapid antigen detection test for the diagnosis of SARS-CoV-2. PLOS ONE. 2021;16 doi: 10.1371/JOURNAL.PONE.0259527. 10.1371/JOURNAL.PONE.0259527 PMC8629250 34843505 Osterman A., Baldauf H.M., Eletreby M., Wettengel J.M., Afridi S.Q., Fuchs T., et al. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med Microbiol Immunol. 2021;210:65–72. doi: 10.1007/S00430-020-00698-8. 10.1007/S00430-020-00698-8 PMC7811156 33452927 Sazed S.A., Kibria M.G., Hossain M.S., Zamil M.F., Adhikary P.C., Hossain M.E., et al. Clinical evaluation of a new antigen-based COVID-19 rapid diagnostic test from symptomatic patients. Diagnostics (Basel) 2021;11:2300. doi: 10.3390/DIAGNOSTICS11122300. 10.3390/DIAGNOSTICS11122300 PMC8699944 34943537 Akashi Y., Horie M., Takeuchi Y., Togashi K., Adachi Y., Ueda A., et al. A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 rapid antigen test using anterior nasal samples. J Infect Chemother. 2022;28:780–785. doi: 10.1016/J.JIAC.2022.02.016. 10.1016/J.JIAC.2022.02.016 PMC8866084 35256268 Brihn A., Chang J., OYong K., Balter S., Terashita D., Rubin Z., et al. Diagnostic performance of an antigen test with RT-PCR for the detection of SARS-CoV-2 in a hospital setting – Los Angeles County, California, June-August 2020. MMWR Morb Mortal Wkly Rep. 2021;70:702–706. doi: 10.15585/MMWR.MM7019A3. 10.15585/MMWR.MM7019A3 PMC8118154 33983916 Krüger L.J., Klein J.A.F., Tobian F., Gaeddert M., Lainati F., Klemm S., et al. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDxTM: an antigen-detecting point-of-care device for SARS-CoV-2. Infection. 2022;50:395–406. doi: 10.1007/S15010-021-01681-Y. 10.1007/S15010-021-01681-Y PMC8358901 34383260 Leli C., Di Matteo L., Gotta F., Cornaglia E., Vay D., Megna I., et al. Performance of a SARS-CoV-2 antigen rapid immunoassay in patients admitted to the emergency department. Int J Infect Dis. 2021;110:135–140. doi: 10.1016/J.IJID.2021.07.043. 10.1016/J.IJID.2021.07.043 PMC8295062 34302961 Mitchell S.L., Orris S., Freeman T., Freeman M.C., Adam M., Axe M., et al. Performance of SARS-CoV-2 antigen testing in symptomatic and asymptomatic adults: a single-center evaluation. BMC Infect Dis. 2021;21:1071. doi: 10.1186/S12879-021-06716-1. 10.1186/S12879-021-06716-1 PMC8521263 34663212 Schuit E., Venekamp R.P., Veldhuijzen I.K., van den Bijllaardt W., Pas S.D., Stohr J.J.J.M., et al. Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study. BMC Med. 2022;20:406. doi: 10.1186/S12916-022-02603-X. 10.1186/S12916-022-02603-X PMC9590385 36280827 Siddiqui Z.K., Chaudhary M., Robinson M.L., McCall A.B., Peralta R., Esteve R., et al. Implementation and accuracy of BinaxNOW rapid antigen COVID-19 test in asymptomatic and symptomatic populations in a high-volume self-referred testing site. Microbiol Spectr. 2021;9 doi: 10.1128/SPECTRUM.01008-21. 10.1128/SPECTRUM.01008-21 PMC8668078 34851137 Van der Moeren N., Zwart V.F., Goderski G., Rijkers G.T., van den Bijllaardt W., Veenemans J., et al. Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL. J Clin Virol. 2021;141 doi: 10.1016/J.JCV.2021.104909. 10.1016/J.JCV.2021.104909 PMC8264273 34271540 Agulló V., Fernández-González M., Ortiz de la Tabla V., Gonzalo-Jiménez N., García J.A., Masiá M., et al. Evaluation of the rapid antigen test PanBio COVID-19 in saliva and nasal swabs in a population-based point-of-care study. J Infect. 2021;82:186–230. doi: 10.1016/J.JINF.2020.12.007. 10.1016/J.JINF.2020.12.007 PMC7725051 33309541 Almendares O., Prince-Guerra J.L., Nolen L.D., Gunn J.K.L., Dale A.P., Buono S.A., et al. Performance characteristics of the Abbott BinaxNOW SARS-CoV-2 antigen test in comparison to real-time reverse transcriptase PCR and viral culture in community testing sites during November 2020. J Clin Microbiol. 2022;60 doi: 10.1128/JCM.01742-21. 10.1128/JCM.01742-21 PMC8769733 34705535 Drain P., Sulaiman R., Hoppers M., Lindner N.M., Lawson V., Ellis J.E. Performance of the LumiraDx microfluidic immunofluorescence point-of-care SARS-CoV-2 antigen test in asymptomatic adults and children. Am J Clin Pathol. 2022;157:602–607. doi: 10.1093/AJCP/AQAB173. 10.1093/AJCP/AQAB173 PMC8973256 34668536 Martín-sánchez V., Fernández-villa T., Carvajal Urueña A., Rivero Rodríguez A., Reguero Celada S., Sánchez Antolín G., et al. Role of rapid antigen testing in population-based SARS-CoV-2 screening. J Clin Med. 2021;10:3854. doi: 10.3390/JCM10173854. 10.3390/JCM10173854 PMC8432187 34501297 Nelson E.J., McKune S.L., Ryan K.A., Shapiro J., Mott-Young A.H., Myers P.D., et al. Antigen vs RT-PCR tests for screening quarantined students in Florida during the COVID-19 pandemic SARS-CoV-2 Delta variant surge. JAMA Pediatr. 2022;176:525–526. doi: 10.1001/JAMAPEDIATRICS.2022.0080. 10.1001/JAMAPEDIATRICS.2022.0080 PMC8902689 35254393 Peacock W.F., Soto-Ruiz K.M., House S.L., Cannon C.M., Headden G., Tiffany B., et al. Utility of COVID-19 antigen testing in the emergency department. J Am Coll Emerg Physicians Open. 2022;3 doi: 10.1002/EMP2.12605. 10.1002/EMP2.12605 PMC8760952 35072154 Schuit E., Veldhuijzen I.K., Venekamp R.P., Van Den Bijllaardt W., Pas S.D., Lodder E.B., et al. Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study. BMJ. 2021;374:n1676. doi: 10.1136/BMJ.N1676. 10.1136/BMJ.N1676 PMC8314145 34315770 Tinker S.C., Szablewski C.M., Litvintseva A.P., Drenzek C., Voccio G.E., Hunter M.A., et al. Point-of-care antigen test for SARS-CoV-2 in asymptomatic college students. Emerg Infect Dis. 2021;27:2662–2665. doi: 10.3201/EID2710.210080. 10.3201/EID2710.210080 PMC8462309 34399086 Torres I., Poujois S., Albert E., Colomina J., Navarro D. Evaluation of a rapid antigen test (PanBioTM COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin Microbiol Infect. 2021;27:636.e1–636.e4. doi: 10.1016/J.CMI.2020.12.022. 10.1016/J.CMI.2020.12.022 PMC7833843 33421573 Aranaz-Andrés J.M., Chávez A.C.F., Laso A.M.G., Abreu M., Núñez P.M., Galán J.C., et al. Analysis of the diagnostic accuracy of rapid antigenic tests for detection of SARS-CoV-2 in hospital outbreak situation. Eur J Clin Microbiol Infect Dis. 2022;41:305–312. doi: 10.1007/S10096-021-04346-8. 10.1007/S10096-021-04346-8 PMC8600491 34792699 Barnacle J.R., Houston H., Baltas I., Takata J., Kavallieros K., Vaughan N., et al. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions. J Hosp Infect. 2022;123:92–99. doi: 10.1016/J.JHIN.2022.02.010. 10.1016/J.JHIN.2022.02.010 PMC8863956 35217130 Caruana G., Lebrun L.L., Aebischer O., Opota O., Urbano L., de Rham M., et al. The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. New Microbe. New Infect. 2021;42 doi: 10.1016/J.NMNI.2021.100899. 10.1016/J.NMNI.2021.100899 PMC8119292 34007453 Demuth S., Damaschek S., Schildgen O., Schildgen V. Low sensitivity of SARS-CoV-2 rapid antigen self-tests under laboratory conditions. New Microbe New Infect. 2021;43 doi: 10.1016/J.NMNI.2021.100916. 10.1016/J.NMNI.2021.100916 PMC8276565 34277011 Ferguson J., Dunn S., Best A., Mirza J., Percival B., Mayhew M., et al. Validation testing to determine the sensitivity of lateral flow testing for asymptomatic SARS-CoV-2 detection in low prevalence settings: testing frequency and public health messaging is key. PLOS Biol. 2021;19 doi: 10.1371/JOURNAL.PBIO.3001216. 10.1371/JOURNAL.PBIO.3001216 PMC8112643 33914730 Fernandez-Montero A., Argemi J., Rodríguez J.A., Ariño A.H., Moreno-Galarraga L. Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values. EClinicalMedicine. 2021;37 doi: 10.1016/J.ECLINM.2021.100954. 10.1016/J.ECLINM.2021.100954 PMC8189541 34127960 Finch L.S., Harris A., Lester C., Veal D., Jones K., Fulton J., et al. Implementation study of SARS-CoV-2 antigen lateral flow tests in men’s professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic. J Infect. 2022;84 doi: 10.1016/J.JINF.2021.12.037. e3–5. 10.1016/J.JINF.2021.12.037 PMC8717709 34974058 Garciá-Fiñana M., Hughes D.M., Cheyne C.P., Burnside G., Stockbridge M., Fowler T.A., et al. Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ. 2021;374:n1637. doi: 10.1136/BMJ.N1637. 10.1136/BMJ.N1637 PMC8259455 34230058 Kumar K., Sampritha U., Maganty V., Prakash A., Basumatary J., Adappa K., et al. Pre-operative SARS CoV-2 rapid antigen test and reverse transcription polymerase chain reaction: a conundrum in surgical decision making. Indian J Ophthalmol. 2021;69:1560–1562. doi: 10.4103/IJO.IJO_430_21. 10.4103/IJO.IJO_430_21 PMC8302313 34011741 Mungomklang A., Trichaisri N., Jirachewee J., Sukprasert J., Tulalamba W., Viprakasit V. Limited sensitivity of a rapid SARS-CoV-2 antigen detection assay for surveillance of asymptomatic individuals in Thailand. Am J Trop Med Hyg. 2021;105:1505–1509. doi: 10.4269/AJTMH.21-0809. 10.4269/AJTMH.21-0809 PMC8641330 34634778 Okoye N.C., Barker A.P., Curtis K., Orlandi R.R., Snavely E.A., Wright C., et al. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting. J Clin Microbiol. 2021;59 doi: 10.1128/JCM.03282-20. e03282–20. 10.1128/JCM.03282-20 PMC8092740 33509809 Qahtani M.A., Yang C.W.T., Lazosky L., Li X., D’cruz J., Romney M.G., et al. SARS-CoV-2 rapid antigen testing for departing passengers at Vancouver International Airport. J Travel Med. 2021;28:taab085. doi: 10.1093/JTM/TAAB085. 10.1093/JTM/TAAB085 PMC8194614 34046663 Shrestha B., Neupane A.K., Pant S., Shrestha A., Bastola A., Rajbhandari B., et al. Sensitivity and specificity of lateral flow antigen test kits for COVID-19 in asymptomatic population of quarantine centre of province 3. Kathmandu Univ Med J (KUMJ) 2020;18:36–39. 33605236 Šterbenc A., Tomič V., Bidovec Stojković U., Vrankar K., Rozman A., Zidarn M. Usefulness of rapid antigen testing for SARS-CoV-2 screening of healthcare workers: a pilot study. Clin Exp Med. 2022;22:157–160. doi: 10.1007/S10238-021-00722-Y. 10.1007/S10238-021-00722-Y PMC8140308 34021827 Thakur P., Saxena S., Manchanda V., Rana N., Goel R., Arora R. Utility of antigen-based rapid diagnostic test for detection of SARS-CoV-2 virus in routine hospital settings. Lab Med. 2021;52:e154–e158. doi: 10.1093/LABMED/LMAB033. 10.1093/LABMED/LMAB033 PMC8135470 33928384 Visci G., Zunarelli C., Violante F., Boffetta P. Application of SARS-CoV-2 antigenic test in asymptomatic workers: sensitivity and specificity of the test. Med Lav. 2021;112:340–345. doi: 10.23749/MDL.V112I5.12097. 10.23749/MDL.V112I5.12097 PMC8600576 34726662 Baro B., Rodo P., Ouchi D., Bordoy A.E., Saya Amaro E.N., Salsench S.V., et al. Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. J Infect. 2021;82:269–275. doi: 10.1016/J.JINF.2021.04.009. 10.1016/J.JINF.2021.04.009 PMC8053403 33882299 Guo C., Yao L., Chen F., Zhang C., Chen W. Development and performance verification of colloidal gold labeled SARS-CoV-2 antigen detection method for routine popular screening of COVID-19 with clinical samples in Poland and China. MedRxiv. 2021:2021. doi: 10.1101/2021.11.22.21266719. 10.1101/2021.11.22.21266719 Patriquin G., LeBlanc J.J., Williams C., Hatchette T.F., Ross J., Barrett L., et al. Comparison between nasal and nasopharyngeal swabs for SARS-CoV-2 rapid antigen detection in an asymptomatic population, and direct confirmation by RT-PCR from the residual buffer. Microbiol Spectr. 2022;10 doi: 10.1128/SPECTRUM.02455-21. 10.1128/SPECTRUM.02455-21 PMC8849095 35171010 Pilecky M., Harm S., Bauer C., Zottl J., Emprechtinger R., Eichhorn T., et al. Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR. J Infect. 2022;84:579–613. doi: 10.1016/J.JINF.2022.01.013. 10.1016/J.JINF.2022.01.013 PMC8758200 35033581 Rottenstreich A., Zarbiv G., Kabiri D., Porat S., Sompolinsky Y., Reubinoff B., et al. Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery. Am J Obstet Gynecol. 2021;224:539–540. doi: 10.1016/J.AJOG.2021.01.002. 10.1016/J.AJOG.2021.01.002 PMC7837133 33453181 Tauh T., Lee S.M., Meyler P., Mozel M., McLennan M., Hoang L.M.N. Diagnostic performance and clinical application of preoperative COVID-19 bedside testing with ID NOWTM. Can J Anaesth. 2021;68:1569–1571. doi: 10.1007/S12630-021-02035-W. 10.1007/S12630-021-02035-W PMC8139543 34021477 Prince-Guerra JL, Almendares O, Nolen LD, Gunn JKL, Dale AP, Buono SA, et al. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70:100-105. 10.15585/mmwr.mm7003e3. 10.15585/mmwr.mm7003e3 PMC7821766 33476316 Beck E.T., Paar W., Fojut L., Serwe J., Jahnke R.R. Comparison of the Quidel sofia SARS FIA test to the Hologic aptima SARS-CoV-2 TMA test for diagnosis of COVID-19 in symptomatic outpatients. J Clin Microbiol. 2021;59 doi: 10.1128/jcm.02727-20. 10.1128/jcm.02727-20 PMC8111148 33239376 Domínguez Fernández M, Seoane Estévez A, Lamelo Alfonsín F, Bou G. Usefulness of the Lumiradx™ SARS-COV-2 antigen test in nursing home. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Aug-Sep;40:404-405. 10.1016/j.eimce.2022.04.008. 10.1016/j.eimce.2022.04.008 PMC9078346 35537994 Turcato G., Zaboli A., Pfeifer N., Ciccariello L., Sibilio S., Tezza G., et al. Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: A preliminary report. J Infect. 2021;82:e14–e16. doi: 10.1016/j.jinf.2020.12.012. 10.1016/j.jinf.2020.12.012 PMC7748975 33347944 trying2... trying... trying2...
Update of European Society of Clinical Microbiology and Infectious Diseases coronavirus disease 2019 guidelines: diagnostic testing for severe acute respiratory syndrome coronavirus 2. | LitMetric
Scope : Since the onset of COVID-19, several assays have been deployed for the diagnosis of SARS-CoV-2. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) published the first set of guidelines on SARS-CoV-2 in vitro diagnosis in February 2022. Because the COVID-19 landscape is rapidly evolving, the relevant ESCMID guidelines panel releases an update of the previously published recommendations on diagnostic testing for SARS-CoV-2. This update aims to delineate the best diagnostic approach for SARS-CoV-2 in different populations based on current evidence.Methods : An ESCMID COVID-19 guidelines task force was established by the ESCMID Executive Committee. A small group was established, half appointed by the chair, and the remaining selected with an open call. The panel met virtually once a week. For all decisions, a simple majority vote was used. A list of clinical questions using the population, intervention, comparison, and outcome (PICO) format was developed at the beginning of the process. For each PICO, 2 panel members performed a literature search focusing on systematic reviews with a third panellist involved in case of inconsistent results. The panel reassessed the PICOs previously defined as priority in the first set of guidelines and decided to address 49 PICO questions, because 6 of them were discarded as outdated/non-clinically relevant. The 'Grading of Recommendations Assessment, Development and Evaluation (GRADE)-adoption, adaptation, and de novo development of recommendations (ADOLOPMENT)' evidence-to-decision framework was used to produce the guidelines.Questions Addressed By The Guidelines And Recommendations : After literature search, we updated 16 PICO questions; these PICOs address the use of antigen-based assays among symptomatic and asymptomatic patients with different ages, COVID-19 severity status or risk for severe COVID-19, time since the onset of symptoms/contact with an infectious case, and finally, types of biomaterials used.
Publication Analysis
Top Keywords
microbiology infectious
8
Similar Publications
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!